论文部分内容阅读
目的:分析泮托拉唑钠联合生长抑素联合用药对急性重症胰腺炎患者病情恢复产生的影响,分析联合用药的价值。方法:选取我院的急性重症胰腺炎患者90例,随机分组法分为观察组和对照组各45人。对照组静脉注射泮托拉唑钠,观察组患者加用生长抑素,重点就治疗效果、并发症发生情况和体征变化情况等,对两组进行对比分析。结果:在治疗有效程度方面,观察组(91.11%)明显优于对照组(80.0%);从并发症发生情况看,观察组并发症的发生率明显小于对对照组,症状恢复正常的时间也明显短于对照组;两组数据统计学比较有意义。结论:联合用药效果显著,能够加快患者病情的恢复,降低术后并发症的发生率,对于疾病的预后改善和生命安全的保障具有重要的积极意义;临床应用价值高值得推行。
Objective: To analyze the influence of combination of pantoprazole sodium and somatostatin on the recovery of patients with acute severe pancreatitis and to analyze the value of combination therapy. Methods: Ninety patients with acute severe pancreatitis in our hospital were randomly divided into observation group and control group with 45 in each group. Control group intravenous injection of pantoprazole sodium, observation group patients with somatostatin, focusing on the treatment effect, complications and signs and other changes, the two groups were compared. Results: In the treatment group, the observation group (91.11%) was significantly better than the control group (80.0%); from the complications, the incidence of complications in the observation group was significantly less than that in the control group, and the time to normal symptoms returned Significantly shorter than the control group; statistical significance of the two groups of data. Conclusion: The combination therapy has significant effect, which can accelerate the recovery of patients’ condition and reduce the incidence of postoperative complications. It is of great significance for the improvement of prognosis and protection of life safety. The value of clinical application should be promoted.